Non-linear association of serum 25-hydroxyvitamin D with urinary albumin excretion rate in normoalbuminuric subjects

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Oh, Yun Jung ^a,b   Park, Rae Woong ^c,d   Yoon, Dukyong ^d   Kim, Myounghee ^e   Han, Seung Seok ^a   Jang, Hye Ryoun ^f   Kim, Hyosang ^g   Heo, Nam Ju ^h   Park, Su Kil ^g   Lee, Hajeong ^a   Joo, Kwon Wook ^a   Lim, Chun Soo ^a   Kim, Yon Su ^a   Kim, Dong Ki ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Cheju Halla General Hospital   (South Korea)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Ajou University School of Medicine   (South Korea)

^e Eulji University   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

Author keywords

Epidemiology; Low grade albuminuria; Threshold; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; RENAL SYSTEM PARAMETERS; URINARY ALBUMIN CREATININE RATIO; URINARY ALBUMIN EXCRETION; URINARY EXCRETION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ALBUMINURIA; ALGORITHM; ANALOGS AND DERIVATIVES; BIOLOGICAL MODEL; BLOOD; COMPUTER SIMULATION; MIDDLE AGED; NONLINEAR SYSTEM; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOUTH KOREA; STATISTICS; URINE;

ALBUMINURIA; ALGORITHMS; BIOLOGICAL MARKERS; COMPUTER SIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; VITAMIN D;

EID: 84903944596     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-97     Document Type: Article

References (44)

1. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Keane WF, Eknoyan G, Am J Kidney Dis 1999 33 5 1004 1010
2. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G, Kidney Int 1998 53 5 1209 1216
3. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE, Circulation 2002 106 14 1777 1782
4. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT, Lancet 2010 375 9731 2073 2081
5. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal SK, Kimm H, Kronenberg F, Oien CM, Levey AS, Levin A, Woodward M, Hemmelgarn BR, BMJ 2013 346 324
6. Estimated GFR, albuminuria, and complications of chronic kidney disease. Inker LA, Coresh J, Levey AS, Tonelli M, Muntner P, J Am Soc Nephrol 2011 22 12 2322 2331
7. Vitamin D deficiency. Holick MF, N Engl J Med 2007 357 3 266 281
8. Alterations in serum levels of 1 alpha,25(OH)2 D3 and osteocalcin in patients with early diabetic nephropathy. Inukai T, Fujiwara Y, Tayama K, Aso Y, Takemura Y, Diabetes Res Clin Pract 1997 38 1 53 59
9. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL, Kidney Int 2007 71 1 31 38
10. Association of Kidney Function, Vitamin D Deficiency, and Circulating Markers of Mineral and Bone Disorders in CKD. Urena-Torres P, Metzger M, Haymann JP, Karras A, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Houillier P, Stengel B, Am J Kidney Dis 2011 58 4 544 553
11. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. Isakova T, Gutierrez OM, Patel NM, Andress DL, Wolf M, Levin A, J Ren Nutr 2011 21 4 295 302
12. Vitamin D levels and patient outcome in chronic kidney disease. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C, Kidney Int 2009 75 1 88 95
13. Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Sikaris KA, Ebeling PR, Chadban SJ, Atkins RC, Kerr PG, Shaw JE, Polkinghorne KR, Am J Kidney Dis 2013 62 1 58 66
14. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS, Am J Kidney Dis 2007 50 1 69 77
15. Vitamin D deficiency and risk of cardiovascular disease. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS, Circulation 2008 117 4 503 511
16. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Melamed ML, Michos ED, Post W, Astor B, Arch Intern Med 2008 168 15 1629 1637
17. Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents. Ashraf A, Alvarez J, Saenz K, Gower B, McCormick K, Franklin F, J Clin Endocrinol Metab 2009 94 9 3200 3206
18. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaelsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL, Sesso HD, Circ Cardiovasc Qual Outcomes 2012 5 6 819 829
19. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. de Boer IH, Levin G, Robinson-Cohen C, Biggs ML, Hoofnagle AN, Siscovick DS, Kestenbaum B, Ann Intern Med 2012 156 9 627 634
20. Non-Linear Relationship between Serum 25-Hydroxyvitamin D and Hemoglobin in Korean Females: The Korean National Health and Nutrition Examination Survey 2010-2011. Han SS, Kim M, Kim H, Lee SM, Oh YJ, Lee JP, Kim S, Joo KW, Lim CS, Kim YS, Kim DK, PLoS One 2013 8 8 72605
21. Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population. Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Rasmussen K, Fenger M, Rossing P, Linneberg A, Endocrine 2013 44 2 473 480
22. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bolstad BM, Irizarry RA, Astrand M, Speed TP, Bioinformatics 2003 19 2 185 193
23. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003 42 4 Suppl 3 1 S201
24. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC, Kidney Int 2009 76 9 977 983
25. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Ann Intern Med 2006 145 4 247 254
26. Exploring the nature of covariate effects in the proportional hazards model. Hastie T, Tibshirani R, Biometrics 1990 46 4 1005 1016
27. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P, Ann Intern Med 2003 139 11 901 906
28. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S, JAMA 2001 286 4 421 426
29. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS, Circulation 2005 112 7 969 975
30. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J, Am J Epidemiol 2008 167 10 1226 1234
31. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J, Am J Kidney Dis 2010 55 4 648 659
32. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. White SL, Polkinghorne KR, Atkins RC, Chadban SJ, Am J Kidney Dis 2010 55 4 660 670
33. The reasons for geographic and racial differences in stroke study: objectives and design. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G, Neuroepidemiology 2005 25 3 135 143
34. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A, Diabetologia 1989 32 4 219 226
35. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction - the Hoorn Stud. Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Kidney Int Suppl 2004 92 42 S44
36. Albuminuria in heart failure: what do we really know? Dobre D, Nimade S, de Zeeuw D, Curr Opin Cardiol 2009 24 2 148 154
37. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. Stehouwer CD, Smulders YM, J Am Soc Nephrol 2006 17 8 2106 2111
38. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, Kavtaradze N, Uphoff I, Hooper C, Tangpricha V, Alexander RW, Brigham K, Quyyumi AA, J Am Coll Cardiol 2011 58 2 186 192
39. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG, Arterioscler Thromb Vasc Biol 2012 32 11 2794 2802
40. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP, J Clin Invest 2002 110 2 229 238
41. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. Rigby WF, Denome S, Fanger MW, J Clin Invest 1987 79 6 1659 1664
42. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, Stein JH, PLoS One 2012 7 5 36617
43. Effects of Vitamin D supplementation on markers of vascular function after myocardial infarction-a randomised controlled trial. Witham MD, Dove FJ, Khan F, Lang CC, Belch JJ, Struthers AD, Int J Cardiol 2013 167 3 745 749
44. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM, Macdonald HM, J Clin Endocrinol Metab 2012 97 10 3557 3568